Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Astrana Health | ASTH | Nov 26, 2024 | 42.46 | +0.14 |
AstraZeneca ADR | AZN | Nov 26, 2024 | 66.36 | -0.06 |
Astria Therapeutics | ATXS | Nov 26, 2024 | 10.30 | +3.00 |
Astronics | ATRO | Nov 26, 2024 | 15.66 | -11.07 |
AstroNova | ALOT | Nov 26, 2024 | 15.19 | +2.22 |
Astrotech | ASTC | Nov 26, 2024 | 7.71 | +1.18 |
Asure Software | ASUR | Nov 26, 2024 | 9.65 | -1.23 |
AT&T | T | Nov 26, 2024 | 23.09 | -0.04 |
AT&T A Pref | T-A | Nov 26, 2024 | 21.32 | -1.07 |
AT&T C Pref | T-C | Nov 26, 2024 | 20.21 | -0.64 |
ATA Creativity Global ADR | AACG | Nov 26, 2024 | 1.02 | 0.00 |
Atai Life Sciences BV | ATAI | Nov 26, 2024 | 1.69 | +0.60 |
Atara Biotherapeutics | ATRA | Nov 26, 2024 | 12.26 | +1.16 |
Atea Pharmaceuticals | AVIR | Nov 26, 2024 | 3.30 | -2.94 |
Aterian | ATER | Nov 26, 2024 | 2.57 | -1.91 |
Athena Technology Acquisition II | ATEK | Nov 26, 2024 | 11.93 | +1.79 |
Athene A Pref | ATH-A | Nov 26, 2024 | 25.20 | -0.20 |
Athene B Pref | ATH-B | Nov 26, 2024 | 21.77 | -1.98 |
Athene C Pref | ATH-C | Nov 26, 2024 | 25.30 | +0.08 |
Athene D Pref | ATH-D | Nov 26, 2024 | 19.11 | -1.65 |
Athene Holding | ATH-E | Nov 26, 2024 | 26.75 | -1.29 |
Athira Pharma | ATHA | Nov 26, 2024 | 0.62 | -1.20 |
Ati Physical Therapy A | ATIP | Nov 26, 2024 | 1.71 | -2.84 |
ATIF Holdings | ATIF | Nov 26, 2024 | 0.62 | -8.22 |
Atkore | ATKR | Nov 26, 2024 | 94.95 | +0.36 |
Atlanta Braves A | BATRA | Nov 26, 2024 | 41.79 | -0.67 |
Atlanta Braves C | BATRK | Nov 26, 2024 | 40.08 | -0.42 |
Atlantic American | AAME | Nov 26, 2024 | 1.53 | -3.16 |
Atlantic Coastal Acquisition II A | ACAB | Nov 26, 2024 | 5.77 | 0.00 |
Atlantic Union Bank | AUB | Nov 26, 2024 | 42.57 | -2.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.